NCM
Nantahala Capital Management’s Fulcrum Therapeutics FULC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $29.5M | Sell |
4,288,299
-534,394
| -11% | -$3.68M | 1.16% | 11 |
|
|
2025
Q1 | $13.9M | Buy |
4,822,693
+42,985
| +0.9% | +$124K | 0.55% | 21 |
|
|
2024
Q4 | $22.5M | Buy |
4,779,708
+1,796
| +0% | +$8.44K | 0.96% | 14 |
|
|
2024
Q3 | $17.1M | Buy |
+4,777,912
| New | +$17.1M | 0.86% | 18 |
|
|
2023
Q3 | – | Sell |
-21,370
| Closed | -$70.5K | – | 119 |
|
|
2023
Q2 | $70.5K | Hold |
21,370
| – | – | 0.01% | 104 |
|
|
2023
Q1 | $60.9K | Sell |
21,370
-478,630
| -96% | -$1.36M | ﹤0.01% | 106 |
|
|
2022
Q4 | $3.64M | Buy |
+500,000
| New | +$3.64M | 0.24% | 48 |
|